SCHEMBL19924193

SCHEMBL19924193

CCCCC(CNC(C)=O)Nc1nc(NCc2ccc(OC)cc2OC)nc2cc(F)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 5/20 0.46
▸ CYP2D6 P10635 3/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ TSHR P16473 3/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ DRD1 P21728 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ TYRO3 Q06418 1/20 0.39
▸ MERTK Q12866 1/20 0.39
▸ GAS6 Q14393 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ CYP2C9 P11712 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924192 1.00 KCNH2 (0.46) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19924247 0.92 KCNH2 (0.42) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19924246 0.92 KCNH2 (0.42) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19924285 0.90 CYP1A2 (0.48) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19924284 0.90 CYP1A2 (0.48) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL30076248 0.90 CYP1A2 (0.48) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19991841 0.89 FLT3 (0.41) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19991840 0.89 FLT3 (0.41) KCNH2CYP2D6CYP1A2CYP3A4TSHR
SCHEMBL19924243 0.84 PDE4A (0.43) KCNH2TSHRSMN1; SMN2HSD17B10MAPT
SCHEMBL19924245 0.84 PDE4A (0.43) KCNH2TSHRSMN1; SMN2HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12522570-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2026-01-13 — — US disclosed
US-20240254091-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2024-08-01 — — US disclosed
US-11827609-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2023-11-28 — — US disclosed
CN-109923106-B toll-like receptor modulator compounds 吉利德科学公司 2022-09-13 — — CN disclosed
EP-3507276-B1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-11-03 — — EP disclosed
US-11124487-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2021-09-21 — — US disclosed
US-10370342-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2019-08-06 — — US disclosed
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370342-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 KCNH2 4399/4885CYP2D6 4389/4885CYP1A2 4638/4885
US-11124487-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 KCNH2 4399/4885CYP2D6 4389/4885CYP1A2 4638/4885
US-20240254091-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 KCNH2 4399/4885CYP2D6 4389/4885CYP1A2 4638/4885
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 KCNH2 4399/4885CYP2D6 4389/4885CYP1A2 4638/4885
US-11827609-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 KCNH2 4399/4885CYP2D6 4389/4885CYP1A2 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback